Graph showing myopia progression over 5 years with different atropine concentrations, demonstrating initial slowing of myopia and rebound after stopping treatment, with lowest rebound in 0.01% atropine group

Long-term data from the ATOM studies

Myopia Rebound: Why Vision Can Get Worse Again

Myopia rebound refers to an increase in myopia progression after stopping treatment. It can occur when underlying eye growth is still active, particularly in children and adolescents.

Introduction

Many parents assume that once treatment starts, the problem is “fixed”.

In reality:

  • myopia management slows progression
  • it does not stop the underlying growth process completely

What is Myopia rebound?

Myopia rebound is when the axial length increases & vision begins to worsen again after treatment is reduced or stopped.

This most commonly occurs with ceasing Atropine therapy.

Why does Rebound Happen?

The key issue is: the underlying driver axial elongation of the eye may still be active

Treatment works by reducing this growth signal.

When treatment stops: the original stimulus may return

Atropine & Rebound

Rebound is most commonly discussed with atropine therapy.

Clinical Insight

  • higher concentrations (e.g. 0.05%) in the Atom studies were shown to have higher degrees of rebound.
  • Stopping abruptly can increase the risk of rebound
  • Gradual reduction is often considered instead

Optical Treatments & Rebound

Rebound may also occur with optical treatments if:

  • lenses are stopped too early
  • the eye is still actively growing

Learn how these treatments are used in myopia management in children

 Timing Matters

One of the most important decisions is: when to stop treatment

Factors include:

  • age
  • rate of progression
  • stability over time

Long Term Management

Myopia management should be viewed as: a long-term process

Not a short-term intervention

Monitoring Is Essential

Regular reviews allow:

  • assessment of stability
  • adjustment of treatment
  • early detection of rebound

Role of Dr Shanel Sharma

Dr Shanel Sharma focuses on:

  • monitoring axial length progression
  • identifying ongoing risk
  • guiding treatment duration and tapering

The goal is to reduce progression without triggering rebound

Understanding rebound is important when considering newer options.

Learn about new myopia treatments.

Long-Term Treatment options

Once myopia is stable:

Role of Dr Daya Sharma

Dr Daya Sharma  focuses on:

  • assesses stability
  • advises on timing of correction
  • performs laser vision procedures when appropriate

If you are thinking of Vision correction for myopia: try our online vision correction suitability self test.

Concerned About Myopia Getting Worse Again?

If your child’s vision has started to change again, review is important.